HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chenghai Li Selected Research

Polycystic Kidney Diseases (Polycystic Kidney Disease)

9/2012Increasing extracellular matrix collagen level and MMP activity induces cyst development in polycystic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chenghai Li Research Topics

Disease

7Neoplasms (Cancer)
01/2021 - 12/2009
3Inflammation (Inflammations)
01/2021 - 01/2020
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 02/2018
2Tuberculosis (Tuberculoses)
01/2024 - 08/2020
2COVID-19
01/2021 - 01/2020
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2024
1Leiomyoma (Uterine Fibroids)
01/2022
1Hyperthermia
01/2021
1Carcinogenesis
01/2021
1Acute-Phase Reaction
01/2021
1Communicable Diseases (Infectious Diseases)
01/2020
1Infections
01/2019
1Lung Neoplasms (Lung Cancer)
02/2018
1Bone Fractures (Bone Fracture)
01/2018
1Soft Tissue Injuries (Soft Tissue Injury)
01/2018
1Osteoporosis
01/2016
1Hypersensitivity (Allergy)
11/2015
1Disease Progression
09/2012
1Polycystic Kidney Diseases (Polycystic Kidney Disease)
09/2012
1Cysts
09/2012
1Renal Cell Carcinoma (Grawitz Tumor)
11/2011
1Necrosis
11/2011
1Colonic Neoplasms (Colon Cancer)
10/2010
1Pancreatic Neoplasms (Pancreatic Cancer)
04/2010
1Breast Neoplasms (Breast Cancer)
12/2009

Drug/Important Bio-Agent (IBA)

3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 04/2010
2VaccinesIBA
01/2021 - 01/2020
2Metalloproteases (Metalloproteinases)IBA
09/2012 - 12/2009
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2011 - 04/2010
2NF-kappa B (NF-kB)IBA
10/2010 - 04/2010
1Insulin (Novolin)FDA Link
03/2024
1dapagliflozinIBA
03/2024
1Biomarkers (Surrogate Marker)IBA
01/2024
1Nucleic AcidsIBA
01/2024
1CytokinesIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1AntibodiesIBA
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2020
1Antiviral Agents (Antivirals)IBA
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
01/2019
1Tyrosine Kinase InhibitorsIBA
02/2018
1ErbB Receptors (EGF Receptor)IBA
02/2018
1RANK LigandIBA
01/2016
1Interleukin-2 (IL2)IBA
11/2015
1Collagen Type I (Type I Collagen)IBA
09/2012
1Doxycycline (Periostat)FDA LinkGeneric
09/2012
1Matrix Metalloproteinases (MMPs)IBA
09/2012
1CollagenIBA
09/2012
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
09/2012
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
11/2011
1dauricineIBA
10/2010
1maslinic acidIBA
04/2010
1SurvivinIBA
04/2010
1Cyclin D1IBA
04/2010
1CaspasesIBA
04/2010
1Inhibitor of Differentiation Protein 1IBA
12/2009

Therapy/Procedure

7Therapeutics
03/2024 - 01/2018
2Immunomodulation
01/2021 - 01/2020
1High-Intensity Focused Ultrasound Ablation
01/2022
1Punctures
08/2020
1Radiotherapy
02/2018